Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Inflammatory Disease Activity”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01751152
What this trial is testing

A Randomised, Double-blind, Placebo-controlled, Parallel-group Trial to Assess Clinical Efficacy and Safety of NNC0114-0006 in Subjects With Active Crohn's Disease

Who this might be right for
InflammationCrohn's Disease
Novo Nordisk A/S 53
Not applicableUnknownNCT04426747
What this trial is testing

Impact of Barriers and Facilitators to Physical Activity in Patients With Inflammatory Arthritis

Who this might be right for
Inflammatory ArthritisAnkylosing SpondylitisRheumatoid Arthritis+1 more
Groupe Hospitalier Pitie-Salpetriere 200
Post-approval studies (Phase 4)Looking for participantsNCT06257706
What this trial is testing

VECTORS - A Study to Evaluate Transmural Healing as a Treatment Target in Crohn's Disease

Who this might be right for
Moderately to Severely Active Crohn's DiseaseCrohn DiseaseDisease Crohn
Alimentiv Inc. 304
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06725017
What this trial is testing

Evaluate the Efficacy and Safety of Live SK08 Powder in Adult Patients with Active Mild to Moderate Ulcerative Colitis

Who this might be right for
Ulcerative Colitis (UC)
Guangzhou Zhiyi Biotechnology Co., Ltd. 60
Large-scale testing (Phase 3)Study completedNCT04205643
What this trial is testing

CT-P13 (Infliximab) Subcutaneous Administration in Patients With Moderately to Severely Active Ulcerative Colitis (LIBERTY-UC)

Who this might be right for
Ulcerative Colitis
Celltrion 548
Testing effectiveness (Phase 2)Ended earlyNCT00792740
What this trial is testing

Effect of ITF2357 on Mucosal Healing in Patients With Moderate-to-severe Active Crohn's Disease

Who this might be right for
Crohn's Disease
Italfarmaco 51
Testing effectiveness (Phase 2)Study completedNCT01988961
What this trial is testing

Evaluate the Accuracy of a Subset of the Length-109 Probe Set Panel (a Genetic Test) in Predicting Response to Golimumab in Participants With Moderately to Severely Active Ulcerative Colitis

Who this might be right for
Colitis, Ulcerative
Janssen Research & Development, LLC 103
Not applicableUnknownNCT03715673
What this trial is testing

Von Willebrand Antigen and Activity as Novel Biomarkers of Hemostasis in Inflammatory Bowel Disease

Who this might be right for
Inflammatory Bowel DiseasesVon Willebrand Diseases
Assiut University 46
Testing effectiveness (Phase 2)Ended earlyNCT05243641
What this trial is testing

Neratinib and Capmatinib Combination (Phase Ib/II) in Metastatic Breast Cancer and Inflammatory Breast Cancer Patients With Abnormal HER-family and c-Met Pathway Activity as Measured by the CELsignia Signaling Analysis Test

Who this might be right for
Metastatic Breast CancerBreast Cancer
M.D. Anderson Cancer Center 10
Large-scale testing (Phase 3)WithdrawnNCT04643483
What this trial is testing

Test Efficacy, Safety, and Pharmacokinetics of Certolizumab Pegol in Children and Adolescents With Moderately to Severely Active Crohn's Disease

Who this might be right for
Crohn's Disease
UCB Biopharma SRL
Not applicableUnknownNCT02445690
What this trial is testing

Thrombin Generation in Crohn's Disease

Who this might be right for
Crohn DiseaseBlood ClotThrombosis
University of Sao Paulo General Hospital 150
Not applicableUnknownNCT03594708
What this trial is testing

Immunonutrition in Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Baptist Memorial Health Care Corporation 30
Not applicableStudy completedNCT02886689
What this trial is testing

C.O.R.P.U.S.: Observational Cohort of Adult and Child Inflammatory Arthritis in France

Who this might be right for
Arthritis, RheumatoidSpondylitis, AnkylosingArthritis, Psoriatic+1 more
Central Hospital, Nancy, France 5,400
Large-scale testing (Phase 3)Study completedNCT00206674
What this trial is testing

Efficacy (Induction of Response/Remission) and Safety Study in Patients With Moderate to Severe Crohn's Disease

Who this might be right for
Crohn Disease
Genzyme, a Sanofi Company 286
Not applicableNot Yet RecruitingNCT07358923
What this trial is testing

Accuracy of Modified Milan Ultrasound Criteria in Assessing Disease Activity and Severity in Moderate-to-Severe Ulcerative Colitis: a Pilot Study

Who this might be right for
Ulcerative Colitis (UC)
IRCCS San Raffaele 25
Large-scale testing (Phase 3)Study completedNCT00033943
What this trial is testing

Safety and Efficacy of OP2000 (Deligoparin) in the Treatment of Active Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Incara Pharmaceuticals 270
Early research (Phase 1)Study completedNCT04862741
What this trial is testing

Safety, Tolerability, and Pharmacokinetics of Oral NX-13 in Active Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Landos Biopharma Inc. 39
Testing effectiveness (Phase 2)Ended earlyNCT00317369
What this trial is testing

A Dose-finding Study of OPC-6535 in Patients With Active Crohn's Disease

Who this might be right for
Crohn Disease
Otsuka Pharmaceutical Co., Ltd. 29
Not applicableUnknownNCT05705232
What this trial is testing

Inflammatory Marker in Ibd and Peripheral Arthritis

Who this might be right for
IBD-Inflammatory Bowel Disease
Assiut University 150
Large-scale testing (Phase 3)Active Not RecruitingNCT04033445
What this trial is testing

Guselkumab in Participants With Moderately to Severely Active Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Janssen Research & Development, LLC 1,064
Next Page